The University of Waterloo School of Pharmacy is delighted to announce a partnership with Apotex that will help shape the future of pharmaceutical research here at Waterloo. Apotex has been involved with the University since it hired its first co-op students in 1984. To date, the company has hired more than 700 co-op students and over 120 Waterloo graduates from a variety of faculties. Apotex has also helped support a number of student-related initiatives here at the School of Pharmacy. The partnership will focus on supporting graduate students through awards, sponsorship, and research opportunities. To kick-off the budding partnership, Apotex funded the School’s first Research Day that was recently held.
“We are pleased to be able to partner with a great Canadian company like Apotex. By supporting the training of our graduate students, this partnership will increase the pool of talented pharmaceutical scientists in Canada,” says David Edwards, Hallman Director at the School of Pharmacy. “In addition, we are excited to have the opportunity to collaborate on research projects of mutual interest that will ultimately benefit the health of Canadians.”
Dr. Jeremy B. Desai, CEO and President of Apotex, also shared positive remarks on the partnership: “Innovation is at the heart of what we do in order to develop affordable, high quality medicines for millions of patients worldwide. Delivering on this purpose requires a tremendous commitment to research and development, and we are pleased to support the bright minds and new thinking of students at the University of Waterloo.”